Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection

NCT04513158 is registered in ClinicalTrials.gov with Joseph M. Flynn, D.O., MPH as lead sponsor.

NCT NCT04513158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04513158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection
Lead sponsor
Joseph M. Flynn, D.O., MPH
Phase
Phase 2
Overall status
Terminated
Start date
August 14, 2020
Completion date
April 28, 2021
Enrollment
2 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19